ZyVersa Therapeutics held its 2023 annual meeting of stockholders and voted on various proposals, including the election of directors, ratification of auditors, approval of charter amendment to increase capital stock, approval of amendment and restatement of equity incentive plan, and approval of charter amendment for reverse stock split.